TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ORION PHARMA

NeurologyRespiratoryOncology
Specialty

ORION PHARMA is a specialty pharmaceutical company focused on Neurology, Respiratory, Oncology.

1999
Since
7
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 81%
7 drugs Phase 2: 2 Phase 1: 2
Respiratory 8%
0 drugs Phase 1: 5
Oncology 7%
0 drugs Phase 1: 4
Infectious Disease 3%
0 drugs Phase 1: 2

Pipeline Strength Pro

Loading...

Competitors Pro

GSK big-pharma
Infectious Disease, Respiratory, Oncology, Neurology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Oncology, Respiratory
AbbVie big-pharma
Oncology, Neurology, Infectious Disease
Sanofi big-pharma
Oncology, Infectious Disease, Respiratory
Roche big-pharma
Oncology, Neurology, Respiratory